Cancer Research Advance in CKLF-like MARVEL Transmembrane Domain Containing Member Family (Review)

Jia Lu1, Qian-Qian Wu, Ya-Bo Zhou

  • 1School of Basic Medical Hebei Medical University, Beijing, China E-mail : liuweihebmu@hebmu.edu.cn, zhengwei301@sina.cn.

Insights

The CKLF-like MARVEL transmembrane domain-containing family (CMTM) genes are potential tumor suppressors involved in immune and reproductive systems. Research shows CMTMs are linked to cancer development and metastasis, offering diagnostic and therapeutic potential.

Area of Science:

  • Genetics and Molecular Biology
  • Cancer Research
  • Immunology

Background:

  • The CKLF-like MARVEL transmembrane domain-containing family (CMTM) is a newly identified gene family.
  • CMTM gene products exhibit characteristics of both chemokines and the transmembrane-4 superfamily.
  • These genes are located on various human chromosomes and are implicated in several biological systems.

Purpose of the Study:

  • To investigate the role of CMTM genes in tumorigenesis, tumor development, and metastasis.
  • To explore the potential of CMTMs as tumor suppressor genes.
  • To understand the clinical significance of CMTMs in diseases related to the tumor and immune systems.

Main Methods:

  • Gene expression analysis in tumor samples (implied).
  • Bioinformatic analysis of CMTM gene family.
  • Literature review of studies on CMTMs and associated diseases.

Main Results:

  • CMTM genes are found to be dysregulated in various tumors.
  • A strong association between the CMTM family and cancer development, including metastasis, has been identified.
  • CMTMs play significant roles in the immune, male reproductive, and hematopoietic systems.

Conclusions:

  • CMTMs are potential tumor suppressor genes with implications in cancer.
  • The CMTM family is closely linked to tumorigenesis and cancer progression.
  • CMTMs hold significant clinical value for diagnosing and treating cancers and immune-related diseases.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...